SARS-CoV-2 Omicron-B.1.1.529 Leads to Widespread Escape from Neutralizing Antibody Responses

Cell  ·  2022  ·  Impact 8

Wanwisa Dejnirattisai; Jiandong Huo; Daming Zhou; Jiří Zahradník; Piyada Supasa; Chang Liu; Helen M E Duyvesteyn; Helen M Ginn; Alexander J Mentzer; Aekkachai Tuekprakhon; Rungtiwa Nutalai; Beibei Wang; Aiste Dijokaite; Suman Khan; Ori Avinoam; Mohammad Bahar; Donal Skelly; Sandra Adele; Sile Ann Johnson; Ali Amini; Thomas G Ritter; Chris Mason; Christina Dold; Daniel Pan; Sara Assadi; Adam Bellass; Nicola Omo-Dare; David Koeckerling; Amy Flaxman; Daniel Jenkin; Parvinder K Aley; Merryn Voysey; Sue Ann Costa Clemens; Felipe Gomes Naveca; Valdinete Nascimento; Fernanda Nascimento; Cristiano Fernandes da Costa; Paola Cristina Resende; Alex Pauvolid-Correa; Marilda M Siqueira; Vicky Baillie; Natali Serafin; Gaurav Kwatra; Kelly Da Silva; Shabir A Madhi; Marta C Nunes; Tariq Malik; Peter J M Openshaw; J Kenneth Baillie; Malcolm G Semple; Alain R Townsend; Kuan-Ying A Huang; Tiong Kit Tan; Miles W Carroll; Paul Klenerman; Eleanor Barnes; Susanna J Dunachie; Bede Constantinides; Hermione Webster; Derrick Crook; Andrew J Pollard; Teresa Lambe; Neil G Paterson; Mark A Williams; David R Hall; Elizabeth E Fry; Juthathip Mongkolsapaya; Jingshan Ren; Gideon Schreiber; David I Stuart; Gavin R Screaton;

RELATED

Papers      Patents     Grants     Venues     Experts    Cite    Share    Save